Development and evaluation of HIV-1 subtype RNA panels for the standardization of HIV-1NAT assays

被引:12
作者
Lee, Sherwin [1 ]
Wood, Owen [1 ]
Taffs, Rolf E. [1 ]
Hu, Jinjie [1 ]
Machuca, Ana [1 ]
Vallejo, Alejandro [1 ]
Hewlett, Indira [1 ]
机构
[1] US FDA, Mol Virol Lab, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA
关键词
HIV-1; RNA; NAT; working reagents; international standard;
D O I
10.1016/j.jviromet.2006.07.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Multiple nucleic acid-based techniques (NAT) have been implemented for testing blood and plasma donors for HIV-1 RNA which may be detected, at an earlier stage of infection when HIV antigen or antibody is absent or below the limit of detection of current assays. The available NAT assays are based on different technologies. In order to evaluate the performance of nucleic acid-based techniques (NAT assays) and to allow accurate comparisons of results from different assays, it is essential to have well characterized specimens with known copy numbers as a standard. For this purpose, a comprehensive study was conducted to develop two HIV-1 RNA reference panels. The first (Panel 1) was prepared using a single specimen from the HIV-1 group M subtype B and consists of panel members with a wide range of HIV-1 RNA copy numbers. Panel 2 consists of 26 members representing HIV-1 group M subtypes A, C, D, E, F, G and groups O and N. For accurate determination of HIV-1 RNA copy numbers of each member of Panel 2, they were analyzed using various testing platforms/technologies available through the cooperation of five independent laboratories participating in the study. A consensus value for HIV RNA copy number was assigned to each member of Panel 2 based on statistical analysis of the data provided by the participants. Both panels could serve as reference panels to be used by manufacturers of HIV NAT tests to evaluate the sensitivity limits of their assays. (c) 2006 Published by Elsevier B.V.
引用
收藏
页码:287 / 291
页数:5
相关论文
共 11 条
[1]   Short communication - Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from six different African countries [J].
Bibollet-Ruche, F ;
Peeters, M ;
Mboup, S ;
Ekaza, E ;
Gandji, R ;
Torimiro, J ;
Mpoudi, EN ;
Amblard, J ;
Dibanga, G ;
Saidou, M ;
Esu-Williams, E ;
Haesevelde, MV ;
Saman, E ;
Delaporte, E .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (14) :1281-1285
[2]   A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors [J].
Busch, MP ;
Glynn, SA ;
Stramer, SL ;
Strong, DM ;
Caglioti, S ;
Wright, DJ ;
Pappalardo, B ;
Kleinman, SH .
TRANSFUSION, 2005, 45 (02) :254-264
[3]   env Sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area [J].
Corbet, S ;
Müller-Trutwin, MC ;
Versmisse, P ;
Delarue, S ;
Ayouba, A ;
Lewis, J ;
Brunak, S ;
Martin, P ;
Brun-Vezinet, F ;
Simon, F ;
Barre-Sinoussi, F ;
Mauclere, P .
JOURNAL OF VIROLOGY, 2000, 74 (01) :529-534
[4]   GENETIC-VARIATION OF HIV TYPE-1 IN 4 WORLD-HEALTH-ORGANIZATION-SPONSORED VACCINE EVALUATION SITES - GENERATION OF FUNCTIONAL ENVELOPE (GLYCOPROTEIN-160) CLONES REPRESENTATIVE OF SEQUENCE SUBTYPE-A, SUBTYPE-B, SUBTYPE-C, AND SUBTYPE-E [J].
GAO, F ;
YUE, L ;
CRAIG, S ;
THORNTON, CL ;
ROBERTSON, DL ;
MCCUTCHAN, FE ;
BRADAC, JA ;
SHARP, PM ;
HAHN, BH ;
OSMANOV, S ;
BELSEY, EM ;
HEYWARD, W ;
ESPARZA, J ;
GALVAOCASTRO, B ;
VANDEPERRE, P ;
KARITA, E ;
WASI, C ;
SEMPALA, S ;
TUGUME, B ;
BIRYAHWAHO, B ;
RUBSAMENWAIGMANN, H ;
VONBRIESEN, H ;
ESSER, R ;
GREZ, M ;
HOLMES, H ;
NEWBERRY, A ;
RANJBAR, S ;
TOMLINSON, P ;
BRADAC, J ;
MCCUTCHAN, F ;
LOUWAGIE, J ;
HEGERICH, P ;
LOPEZGALINDEZ, C ;
OLIVARES, I ;
DOPAZO, J ;
MULLINS, JI ;
DELWART, EL ;
BACHMANN, HM ;
GOUDSMIT, J ;
DEWOLF, F ;
SARAGOSTI, S ;
SCHOCHETMAN, G ;
KALISH, M ;
LUO, CC ;
GEORGE, R ;
PAU, CP ;
WEBER, J ;
CHEINGSONGPOPOV, R ;
KALEEBU, P ;
NARA, P .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) :1359-1368
[5]   REACTIVITY OF 5 ANTI-HIV-1 SUBTYPE-O SPECIMENS WITH 6 DIFFERENT ANTI-HIV SCREENING ELISAS AND 3 IMMUNOBLOTS [J].
GURTLER, LG ;
ZEKENG, L ;
SIMON, F ;
EBERLE, J ;
TSAGUE, JM ;
KAPTUE, L ;
BRUST, S ;
KNAPP, S .
JOURNAL OF VIROLOGICAL METHODS, 1995, 51 (2-3) :177-183
[6]   QUANTITATION OF HIV-1 RNA IN PLASMA PREDICTS OUTCOME AFTER SEROCONVERSION [J].
MELLORS, JW ;
KINGSLEY, LA ;
RINALDO, CR ;
TODD, JA ;
HOO, BS ;
KOKKA, RP ;
GUPTA, P .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (08) :573-579
[7]   Plasma viral load and CD4(+) lymphocytes as prognostic markers of HIV-1 infection [J].
Mellors, JW ;
Munoz, A ;
Giorgi, JV ;
Margolick, JB ;
Tassoni, CJ ;
Gupta, P ;
Kingsley, LA ;
Todd, JA ;
Saah, AJ ;
Detels, R ;
Phair, JP ;
Rinaldo, CR .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (12) :946-954
[8]   Changes in plasma HIV RNA levels and CD4(+) lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure [J].
OBrien, WA ;
Hartigan, PM ;
Daar, ES ;
Simberkoff, MS ;
Hamilton, JD .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (12) :939-945
[9]   Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor [J].
Phelps, R ;
Robbins, K ;
Liberti, T ;
Machuca, A ;
Leparc, G ;
Chamberland, M ;
Kalish, M ;
Hewlett, I ;
Folks, T ;
Lee, LM ;
McKenna, M .
TRANSFUSION, 2004, 44 (06) :929-933
[10]   RAPID CHANGES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA LOAD AND APPEARANCE OF DRUG-RESISTANT VIRUS POPULATIONS IN PERSONS TREATED WITH LAMIVUDINE (3TC) [J].
SCHUURMAN, R ;
NIJHUIS, M ;
VANLEEUWEN, R ;
SCHIPPER, P ;
DEJONG, D ;
COLLIS, P ;
DANNER, SA ;
MULDER, J ;
LOVEDAY, C ;
CHRISTOPHERSON, C ;
KWOK, S ;
SNINSKY, J ;
BOUCHER, CAB .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (06) :1411-1419